STRO logo

Sutro Biopharma (STRO)

Profile

Full Name

Sutro Biopharma, Inc.

Ticker Symbol

STRO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 27, 2018

Indexes

Not included

Website

http://www.sutrobio.com

Employees

310

Key Details

Price

$0.60(+5.26%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$62.04M(-59.64% YoY)

Annual EPS

-$2.96(-66.29% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.60
STRO price is $0.60

30-Day Relative Volume

0.45
STRO 30-day relative volume is 0.45

Price Performance

Price Most recent change

+5.26%
STRO price was up +5.26% on Apr 11, 2025

Price YTD change

-67.39%
STRO price is down -67.39% since January 1st

Price 1-year change

-85.51%
STRO price is down -85.51% year-on-year

Price 3-year change

-91.74%
STRO price is down -91.74% over the past 3 years

Price Range

Price All-time high

$28.30
STRO price is currently -97.88% below its historical high of $28.30

Price 3-year low

$0.54
STRO price is currently +11.11% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$50.27M
STRO market capitalization is $50.27 million

Market cap 3-year change

-85.25%
STRO market capitalization is down -85.25% over the past 3 years

Market cap All-time high

$1.26B
STRO market capitalization is currently -96.01% below its historical high of $1.26 billion

Market cap sector rank

39.03%
STRO market capitalization is higher than 39.03% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.46%
STRO shares outstanding is up +2.46% year-on-year

Shares Outstanding 3-Year Change

+78.52%
STRO shares outstanding is up +78.52% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.15
STRO beta is 1.15

200-day SMA

$2.78
STRO price is currently -78.38% below its 200-day simple moving average

50-day SMA

$1.27
STRO price is currently -52.64% below its 50-day simple moving average

RSI

33.23
STRO 14-day relative strength index is 33.23

Volume

0.45
STRO 30-day relative volume is 0.45

ATR

$0.10
STRO average true range is $0.10

10-day Historical Volatility

216.98%
STRO 10-day historical volatility is 216.98%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$62.04M
STRO annual revenue is $62.04 million

Revenue Analysts estimate

$47.14M
STRO annual revenue is currently +31.63% higher than the consensus analysts' forecast

Revenue 1-year change

-59.64%
STRO annual revenue is down -59.64% year-on-year

Revenue Sector rank

49.94%
STRO annual revenue is higher than 49.94% of companies in Healthcare sector

EPS

EPS

-$2.96
STRO annual earnings per share is -$2.96

EPS Analysts estimate

-$2.48
STRO annual earnings per share is currently +19.35% higher than the consensus analysts' forecast

EPS 1-year change

-66.29%
STRO annual earnings per share is down -66.29% year-on-year

EPS Sector rank

30.14%
STRO annual earnings per share is higher than 30.14% of companies in Healthcare sector

Profit

Gross profit

-
STRO annual gross profit value is unknown

Gross margin

-
STRO annual gross profit margin value is unknown

Operating profit

-$238.45M
STRO annual operating income is -$238.45 million

Operating margin

-384.34%
STRO annual operating profit margin is -384.34%

Net income

-$227.46M
STRO annual net profit is -$227.46 million

Net margin

-366.62%
STRO annual net profit margin is -366.62%

Expenses

Total expenses

$300.50M
STRO annual total expenses is $300.50 million

Operating expenses

$300.50M
STRO annual total operating expenses is $300.50 million

Cost of goods sold

-
STRO annual cost of goods sold value is unknown

Selling, general & administrative expenses

$48.45M
STRO annual SGA is $48.45 million

Depreciation and amortization

$7.22M
STRO annual depreciation & amortization is $7.22 million

Interest expense

$31.07M
STRO annual interest expense is $31.07 million

Income tax

$2.36M
STRO annual income tax is $2.36 million

EBIT & EBITDA

EBIT

-$194.03M
STRO annual earnings before interest & taxes is -$194.03 million

EBITDA

-$186.81M
STRO annual EBITDA is -$186.81 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$387.21M
STRO annual total assets is $387.21 million

Non current assets

$43.90M
STRO annual long term assets is $43.90 million

Current assets

$343.31M
STRO annual total current assets is $343.31 million

Cash and cash equivalents

$190.30M
STRO annual cash & cash equivalents is $190.30 million

Accounts receivable

$8.62M
STRO annual accounts receivable is $8.62 million

Inventory

-
STRO annual inventory value is unknown

Liabilities

Total liabilities

$342.61M
STRO annual total liabilities is $342.61 million

Long term liabilities

$210.71M
STRO annual total long term liabilities is $210.71 million

Current liabilities

$131.89M
STRO annual total current liabilities is $131.89 million

Accounts payable

$10.47M
STRO annual accounts payable is $10.47 million

Debt

Total debt

$23.15M
STRO annual total debt is $23.15 million

Total debt 1-year change

-31.16%
STRO annual total debt is down -31.16% year-on-year

Long term debt

$15.67M
STRO annual long term debt is $15.67 million

Short term debt

$7.48M
STRO annual short term debt is $7.48 million

Equity & Capital

Shareholders equity

$44.60M
STRO annual stockholders equity is $44.60 million

Book value

$44.60M
STRO annual book value is $44.60 million

Retained earnings

-$786.87M
STRO annual retained earnings is -$786.87 million

Working capital

$211.42M
STRO annual working capital is $211.42 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$191.54M
STRO annual cash flow from operations is -$191.54 million

Cash from operations 1-year change

-71.61%
STRO annual cash flow from operations is down -71.61% year-on-year

Cash from investing

$218.51M
STRO annual cash flow from investing activities is $218.51 million

Cash from investing 1-year change

+5668.5%
STRO annual cash flow from investing activities is up +5668.5% year-on-year

Cash from financing

$94.05M
STRO annual cash flow from financing activities is $94.05 million

Cash from financing 1-year change

-31.62%
STRO annual cash flow from financing activities is down -31.62% year-on-year

CAPEX

CAPEX

$3.10M
STRO annual capital expenditures is $3.10 million

CAPEX 1-year change

-28.2%
STRO annual capital expenditures is down -28.2% year-on-year

Free Cash Flow

Free cash flow

-$194.64M
STRO annual free cash flow is -$194.64 million

Free cash flow 1-year change

-67.89%
STRO annual free cash flow is down -67.89% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
STRO annual gross profit margin value is unknown

Operating margin

-384.34%
STRO annual operating profit margin is -384.34%

Net margin

-366.62%
STRO annual net profit margin is -366.62%

ROA & ROE

ROA

-53.02%
STRO annual return on assets is -53.02%

ROE

-234.19%
STRO annual return on equity is -234.19%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
STRO price to earnings ratio value is unknown

PE ratio Sector rank

-
STRO price to earnings ratio is unknown

PB Ratio

PB ratio

1.13
STRO price to book ratio is 1.13

PB ratio Sector rank

47.29%
STRO price to book ratio is higher than 47.29% of companies in Healthcare sector

PS Ratio

PS ratio

0.81
STRO price to sales ratio is 0.81

PS ratio Sector rank

24.23%
STRO price to sales ratio is higher than 24.23% of companies in Healthcare sector

Enterprise value

Enterprise value

-$116.88M
STRO enterprise value is -$116.88 million

Enterprise value Sector rank

0.41%
STRO enterprise value is higher than 0.41% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.64
STRO EV/EBITDA is 0.64

EV/EBITDA Sector rank

73.07%
STRO EV/EBITDA is higher than 73.07% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.60
STRO annual current ratio is 2.60

Quick ratio

-
STRO annual quick ratio value is unknown

Leverage

Debt to equity

0.00
STRO annual debt to equity ratio is 0.00

Interest coverage ratio

-6.24
STRO annual interest coverage ratio is -6.24

Risk & Stability

Piotroski F-Score

-
STRO piotroski f-score value is unknown

Altman Z-Score

-3.60
STRO altman z-score is -3.60

Analyst ratings

Recent major analysts updates

Mar 17, 25 HC Wainwright & Co.
Neutral
Mar 14, 25 Wedbush
Neutral
Mar 14, 25 Citizens Capital Markets
Market Perform
Mar 14, 25 B of A Securities
Underperform
Dec 11, 24 Wells Fargo
Equal-Weight
Dec 11, 24 JMP Securities
Market Outperform
Nov 18, 24 HC Wainwright & Co.
Buy
Oct 11, 24 Piper Sandler
Overweight
Oct 11, 24 HC Wainwright & Co.
Buy
Sep 16, 24 JMP Securities
Market Outperform

Institutional Ownership

Similar stocks

CCLD logo
CareCloud (CCLD)
SER logo
Serina Therapeutics (SER)
BLUE logo
bluebird bio (BLUE)
ZOM logo
Zomedica (ZOM)
CYCC logo
Cyclacel Pharmaceuticals (CYCC)
Acrivon Therapeutics (ACRV)
NOTV logo
Inotiv (NOTV)
ALVR logo
AlloVir (ALVR)
GUTS logo
Fractyl Health (GUTS)
  • What is the ticker symbol for Sutro Biopharma?
  • Does Sutro Biopharma pay dividends?
  • What sector is Sutro Biopharma in?
  • What industry is Sutro Biopharma in?
  • What country is Sutro Biopharma based in?
  • When did Sutro Biopharma go public?
  • Is Sutro Biopharma in the S&P 500?
  • Is Sutro Biopharma in the NASDAQ 100?
  • Is Sutro Biopharma in the Dow Jones?
  • When was Sutro Biopharma's last earnings report?
  • When does Sutro Biopharma report earnings?
  • Should I buy Sutro Biopharma stock now?

What is the ticker symbol for Sutro Biopharma?

The ticker symbol for Sutro Biopharma is NASDAQ:STRO

Does Sutro Biopharma pay dividends?

No, Sutro Biopharma does not pay dividends

What sector is Sutro Biopharma in?

Sutro Biopharma is in the Healthcare sector

What industry is Sutro Biopharma in?

Sutro Biopharma is in the Biotechnology industry

What country is Sutro Biopharma based in?

Sutro Biopharma is headquartered in United States

When did Sutro Biopharma go public?

Sutro Biopharma's initial public offering (IPO) was on September 27, 2018

Is Sutro Biopharma in the S&P 500?

No, Sutro Biopharma is not included in the S&P 500 index

Is Sutro Biopharma in the NASDAQ 100?

No, Sutro Biopharma is not included in the NASDAQ 100 index

Is Sutro Biopharma in the Dow Jones?

No, Sutro Biopharma is not included in the Dow Jones index

When was Sutro Biopharma's last earnings report?

Sutro Biopharma's most recent earnings report was on Mar 13, 2025

When does Sutro Biopharma report earnings?

The next expected earnings date for Sutro Biopharma is May 13, 2025

Should I buy Sutro Biopharma stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page